Skip to main content

A phase I study of the safety and activation of a cathepsin-activatable fluorescent cancer-specific probe LUM015.

Publication ,  Conference
Whitley, MJ; Cardona, DM; Blazer, DG; Hwang, SE; Mosca, PJ; Cahill, J; Ferrer, JM; Strasfeld, DB; Mito, JK; Cuneo, KC; Larrier, N; Williams, N ...
Published in: Journal of Clinical Oncology
May 20, 2014

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2014

Volume

32

Issue

15_suppl

Start / End Page

TPS11135 / TPS11135

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Whitley, M. J., Cardona, D. M., Blazer, D. G., Hwang, S. E., Mosca, P. J., Cahill, J., … Brigman, B. E. (2014). A phase I study of the safety and activation of a cathepsin-activatable fluorescent cancer-specific probe LUM015. In Journal of Clinical Oncology (Vol. 32, pp. TPS11135–TPS11135). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.tps11135
Whitley, Melodi Javid, Diana M. Cardona, Dan G. Blazer, Shelley E. Hwang, Paul J. Mosca, Joan Cahill, Jorge M. Ferrer, et al. “A phase I study of the safety and activation of a cathepsin-activatable fluorescent cancer-specific probe LUM015.” In Journal of Clinical Oncology, 32:TPS11135–TPS11135. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.tps11135.
Whitley MJ, Cardona DM, Blazer DG, Hwang SE, Mosca PJ, Cahill J, et al. A phase I study of the safety and activation of a cathepsin-activatable fluorescent cancer-specific probe LUM015. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. TPS11135–TPS11135.
Whitley, Melodi Javid, et al. “A phase I study of the safety and activation of a cathepsin-activatable fluorescent cancer-specific probe LUM015.Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. TPS11135–TPS11135. Crossref, doi:10.1200/jco.2014.32.15_suppl.tps11135.
Whitley MJ, Cardona DM, Blazer DG, Hwang SE, Mosca PJ, Cahill J, Ferrer JM, Strasfeld DB, Mito JK, Cuneo KC, Larrier N, Williams N, Spasojevic I, Riedel RF, Eward W, Lee WD, Griffith LG, Bawendi M, Kirsch DG, Brigman BE. A phase I study of the safety and activation of a cathepsin-activatable fluorescent cancer-specific probe LUM015. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. TPS11135–TPS11135.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2014

Volume

32

Issue

15_suppl

Start / End Page

TPS11135 / TPS11135

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences